Published in Free Radic Biol Med on October 01, 2011
Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther (2013) 1.02
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity. Exp Hematol (2013) 0.83
Irradiated human endothelial progenitor cells induce bystander killing in human non-small cell lung and pancreatic cancer cells. Int J Radiat Biol (2016) 0.79
N-[(11)CH3]Dimethylaminoparthenolide (DMAPT) uptake into orthotopic 9LSF glioblastoma tumors in the rat. Bioorg Med Chem Lett (2016) 0.75
Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones. Curr Med Chem (2016) 0.75
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood (2004) 7.21
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol (2012) 3.92
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2004) 2.65
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev (2012) 2.13
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer (2013) 2.10
A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.63
Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group. Clin Cancer Res (2006) 1.60
Use of the Leksell Gamma Knife for localized small field lens irradiation in rodents. Technol Cancer Res Treat (2003) 1.44
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol Med (2012) 1.44
Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. Int J Radiat Oncol Biol Phys (2011) 1.29
Factors impacting human telomere homeostasis and age-related disease. Mech Ageing Dev (2007) 1.28
DNA damage-induced phosphorylation of the human telomere-associated protein TRF2. Proc Natl Acad Sci U S A (2005) 1.24
Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis (2009) 1.20
Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) (2007) 1.18
Oncology outpatient and provider responses to a computerized symptom assessment system. Oncol Nurs Forum (2008) 1.14
Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell (2007) 1.14
Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin Infect Dis (2009) 1.12
Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam. Radiat Res (2012) 1.05
Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene (2002) 1.03
Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther (2013) 1.02
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors. Cancer Chemother Pharmacol (2014) 1.00
The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunction. Stem Cell Reports (2013) 0.99
DNA damage-induced phosphorylation of TRF2 is required for the fast pathway of DNA double-strand break repair. Mol Cell Biol (2009) 0.98
Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. Nanomedicine (Lond) (2012) 0.97
Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A (2012) 0.97
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs (2011) 0.97
Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells. Int J Radiat Oncol Biol Phys (2006) 0.95
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy. Clin Cancer Res (2004) 0.94
Prevalence of arsenic-related skin lesions in 53 widely-scattered villages of Bangladesh: an ecological survey. J Health Popul Nutr (2006) 0.93
Differential mechanisms of x-ray-induced cell death in human endothelial progenitor cells isolated from cord blood and adults. Radiat Res (2011) 0.92
Reconstructive surgery for lower pole ureteropelvic junction obstruction associated with incomplete ureteral duplication. J Pediatr Urol (2009) 0.91
Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull World Health Organ (2007) 0.91
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species. Int J Cancer (2011) 0.91
Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene (2005) 0.89
Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer. Genes Chromosomes Cancer (2008) 0.89
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer. Cancer Chemother Pharmacol (2008) 0.89
Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene (2002) 0.89
Recruitment of TRF2 to laser-induced DNA damage sites. Free Radic Biol Med (2012) 0.89
A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species. Prostate (2010) 0.88
Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia. Br J Haematol (2008) 0.88
Effect of estrogen on radiation-induced cataractogenesis. Radiat Res (2006) 0.87
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs (2010) 0.87
A hierarchy of endothelial colony-forming cell activity displayed by bovine corneal endothelial cells. Invest Ophthalmol Vis Sci (2010) 0.86
Radiation-induced genetic instability in vivo depends on p53 status. Mutat Res (2002) 0.85
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer. Oncology (2005) 0.84
X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells. DNA Repair (Amst) (2007) 0.84
Reduced apoptosis and increased deletion mutations at Aprt locus in vivo in mice exposed to repeated ionizing radiation. Cancer Res (2007) 0.84
Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma. Technol Cancer Res Treat (2006) 0.84
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP). J Natl Cancer Inst (2015) 0.82
Estrogen protects against radiation-induced cataractogenesis. Radiat Res (2008) 0.82
Ovarian hormone modulation of radiation-induced cataractogenesis: dose-response studies. Invest Ophthalmol Vis Sci (2009) 0.81
Going beyond the kidney disease outcomes quality initiative: hemodialysis access experience at Kaiser Permanente Southern California. Ann Vasc Surg (2006) 0.81
Subcutaneous wounding postirradiation reduces radiation lethality in mice. Radiat Res (2014) 0.81
Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair. Radiat Res (2007) 0.80
Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering. Genome Integr (2010) 0.80
Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells. Radiat Res (2009) 0.79
Smoking risk and the likelihood of quitting among African-American female light and heavy smokers. J Natl Med Assoc (2008) 0.78
Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence. Recent Pat CNS Drug Discov (2012) 0.78
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors. Cancer Chemother Pharmacol (2006) 0.78
Management of patients with chronic kidney disease at Kaiser Permanente. Nephrol News Issues (2003) 0.78
Effect of gender on radiation-induced cataractogenesis. Radiat Res (2009) 0.77
Age and hormonal status as determinants of cataractogenesis induced by ionizing radiation. I. Densely ionizing (high-LET) radiation. Radiat Res (2010) 0.77
A radioprotective effect of imatinib (Gleevec) in human squamous carcinoma cells. Strahlenther Onkol (2007) 0.76
A radiation-induced acute apoptosis involving TP53 and BAX precedes the delayed apoptosis and neoplastic transformation of CGL1 human hybrid cells. Radiat Res (2005) 0.76
Testosterone therapy in castrate-resistant prostate cancer: a possible new approach. Eur Urol (2009) 0.75
Effects of estrogen and gender on cataractogenesis induced by high-LET radiation. Radiat Res (2010) 0.75
Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer. N Engl J Med (2016) 0.75
'Charting a new course for prostate cancer' - currying favor for docetaxel in hormone-sensitive metastatic prostate cancer. Expert Rev Anticancer Ther (2014) 0.75
Vascular access management: ongoing challenges and strategies for success. Nephrol News Issues (2014) 0.75
Approach to risk stratification in testicular germ cell tumors: a primer for radiologists. Abdom Imaging (2015) 0.75
Lessons learned from development of docetaxel. Expert Opin Drug Metab Toxicol (2008) 0.75
Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives. Pharm Pat Anal (2014) 0.75
Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system. Prostate (2002) 0.75
Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro. J Vasc Interv Radiol (2007) 0.75
Managing high-risk, high-cost patients: the southern california kaiser permanente experience in the medicare ESRD demonstration project. Perm J (2005) 0.75
Teaching nurses in Bangladesh. Am J Nurs (2013) 0.75
Conivaptan: promise of treatment in heart failure. Expert Opin Pharmacother (2009) 0.75
An unusual case of dysphagia and chest pain in a non-HIV patient: esophageal tuberculosis. Am J Med (2007) 0.75